These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Bacteriophages and endotoxin in licensed live-virus vaccines. Moody EE; Trousdale MD; Jorgensen JH; Shelokov A J Infect Dis; 1975 May; 131(5):588-91. PubMed ID: 805187 [TBL] [Abstract][Full Text] [Related]
5. Stability characteristics of freeze-dried human live virus vaccines. Cowdery S; Frey M; Orlowski S; Gray A Dev Biol Stand; 1976 Oct; 36():297-303. PubMed ID: 1030428 [TBL] [Abstract][Full Text] [Related]
6. New recommendations for simultaneous administration of live virus vaccines. Reeve AM J Iowa Med Soc; 1973 Feb; 63(2):50 passim. PubMed ID: 4687453 [No Abstract] [Full Text] [Related]
7. Monitoring vaccines for human oncogenicity. Miller RW Natl Cancer Inst Monogr; 1968 Dec; 29():453-5. PubMed ID: 4305436 [No Abstract] [Full Text] [Related]
8. Production of vaccines with special reference to rubella vaccine RA 27-3 strain in WI 38 cells. Beale AJ Adv Exp Med Biol; 1972; 31(0):179-86. PubMed ID: 4671959 [No Abstract] [Full Text] [Related]
9. Clinical experience with vaccines produced in the human diploid cell line WI-38. Andzaparidze OG Natl Cancer Inst Monogr; 1968 Dec; 29():477-84. PubMed ID: 4976367 [No Abstract] [Full Text] [Related]
11. Clinical safety issues of measles, mumps and rubella vaccines. Afzal MA; Minor PD; Schild GC Bull World Health Organ; 2000; 78(2):199-204. PubMed ID: 10743285 [TBL] [Abstract][Full Text] [Related]
12. Use of animals in the development and control of viral vaccines. Minor PD Dev Biol Stand; 1996; 86():113-20. PubMed ID: 8785940 [TBL] [Abstract][Full Text] [Related]
13. Markers and vaccines. Kańtoch M Adv Virus Res; 1978; 22():259-325. PubMed ID: 76436 [No Abstract] [Full Text] [Related]
14. Viral vaccines: various cell substrates and long-term prospective studies. Kirschstein RL; Petricciani JC Adv Exp Med Biol; 1972; 31(0):197-206. PubMed ID: 4212515 [No Abstract] [Full Text] [Related]
15. Factors affecting the stability of viral vaccines. Peetermans J Dev Biol Stand; 1996; 87():97-101. PubMed ID: 8854006 [TBL] [Abstract][Full Text] [Related]
16. Application of PCR for detection of mycoplasma DNA and pestivirus RNA in human live viral vaccines. Sasaki T; Harasawa R; Shintani M; Fujiwara H; Sasaki Y; Horino A; Kenri T; Asada K; Kato I; Chino F Biologicals; 1996 Dec; 24(4):371-5. PubMed ID: 9088554 [TBL] [Abstract][Full Text] [Related]
17. Re-evaluation of the basic procedures involved in the storage of measles vaccine in public health units of the municipality of Niterói, State of Rio de Janeiro, Brazil. Oliveira SA; Loureiro ML; Kiffer CR; Maduro LM Rev Soc Bras Med Trop; 1993; 26(3):145-9. PubMed ID: 8146388 [TBL] [Abstract][Full Text] [Related]
18. Storage conditions of live measles, mumps and rubella virus vaccines in Montreal. Steinmetz N; Furesz J; Reinhold C; Yarosh W Can Med Assoc J; 1983 Jan; 128(2):162-3. PubMed ID: 6848162 [No Abstract] [Full Text] [Related]
19. Studies on new attenuated strains of type III live poliomyelitis vaccine. I. Development of a new type III attenuated poliovirus. Chin Med J (Engl); 1980 Sep; 93(9):583-90. PubMed ID: 6253236 [No Abstract] [Full Text] [Related]
20. Measles vaccine failure. A survey of causes and means of prevention. Hayden GF Clin Pediatr (Phila); 1979 Mar; 18(3):155-6, 161-3, 167. PubMed ID: 371890 [No Abstract] [Full Text] [Related] [Next] [New Search]